brain infarction
Information
- Disease name
- brain infarction
- Disease ID
- DOID:3454
- Description
- "A cerebrovascular disease that is characterized by tissue necrosis located_in the brain, resulting from inadequate blood flow through the brain." [url:https\://meshb.nlm.nih.gov/record/ui?ui=D020520]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00126516 | Completed | Phase 4 | Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline | May 2004 | June 2013 |
NCT00871715 | Completed | N/A | Arm Rehabilitation Study After Stroke | June 2009 | February 2014 |
NCT00894803 | Completed | Phase 2 | Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke | July 2009 | December 2012 |
NCT01674452 | Completed | N/A | Home-based Exercises for Patients With Stroke | January 2010 | July 2012 |
NCT01915368 | Completed | N/A | Determining Optimal Post-Stroke Exercise (DOSE) | September 2013 | December 2019 |
NCT01977456 | Completed | Phase 2 | Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR) | September 2013 | April 2015 |
NCT02389894 | Completed | N/A | Neuroprotection in Patients Undergoing Aortic Valve Replacement | March 2015 | January 2017 |
NCT02684825 | Completed | N/A | Detection of Silent Atrial Fibrillation aFter Ischemic StrOke | October 2015 | May 31, 2022 |
NCT03448159 | Completed | Phase 2 | Fluoxetine Opens Window to Improve Motor Recovery After Stroke | January 1, 2019 | September 30, 2022 |
NCT04043559 | Completed | Cortical Cerebellar Infarctions Associated With Patent Foramen Ovale in Young Stroke Patients | July 25, 2019 | December 31, 2020 | |
NCT04232163 | Completed | N/A | Arm Boot Camp Study: Evaluation of a Program to Increase Upper Limb Recovery After Stroke | August 15, 2020 | December 31, 2022 |
NCT04265664 | Completed | N/A | Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke | July 28, 2020 | September 30, 2021 |
NCT04941482 | Completed | N/A | Intervention Effectiveness Towards Improving Physical and Mental Health for Post-stroke Patients. | August 1, 2021 | June 30, 2023 |
NCT05086874 | Completed | Using Real-world Evidence to Analyze the Clinical Effects and Adverse Events of Butylphthalide in Stroke Patients | May 7, 2022 | March 1, 2023 | |
NCT05169450 | Completed | N/A | Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke | July 1, 2013 | April 1, 2014 |
NCT00151177 | Completed | Phase 1/Phase 2 | Continuous Positive Airway Pressure Ventilation After Acute Ischemic Stroke | April 2005 | April 2008 |
NCT00235248 | Completed | Phase 3 | Aortic Arch Related Cerebral Hazard Trial (ARCH) | February 2002 | July 2012 |
NCT00343174 | Completed | Phase 3 | Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms | ||
NCT00829361 | Completed | N/A | Stroke Telemedicine for Arizona Rural Residents Trial | October 2008 | January 2012 |
NCT04908241 | Recruiting | N/A | Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) | November 8, 2021 | August 1, 2024 |
NCT01934725 | Recruiting | Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome | November 2013 | December 2031 | |
NCT04093336 | Recruiting | Phase 1/Phase 2 | Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients | January 13, 2019 | December 30, 2024 |
NCT05884762 | Recruiting | N/A | earlY Upper Limb Rehabilitation WIth EEG-Neurofeedback After Stroke | February 20, 2024 | January 20, 2026 |
NCT05068349 | Recruiting | Phase 4 | For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide. | May 7, 2022 | December 2025 |
NCT01201629 | Terminated | N/A | Transcranial Direct Current Stimulation, Improve Functional Motor Recovery, Affected Arm | September 16, 2010 | December 2015 |
NCT00141011 | Terminated | Phase 3 | Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke | September 2005 | December 2008 |
NCT00300196 | Terminated | Phase 3 | ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke | March 2006 | December 2008 |
NCT01059149 | Terminated | Phase 2 | Safety and Long-term Effectiveness of High Frequency Repetitive Transcranial Magnetic Stimulation of Stroke (RAICup) | November 2010 | December 2011 |
NCT00657969 | Unknown status | Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections | July 2005 | September 2009 | |
NCT02235974 | Unknown status | N/A | Critical Periods After Stroke Study (CPASS) | August 26, 2014 | January 31, 2021 |
NCT04270513 | Unknown status | Flying Intervention Team for Endovascular Treatment of Acute Ischemic Stroke in Rural Areas | February 1, 2018 | April 2020 | |
NCT03318744 | Unknown status | N/A | Antiplatelet Therapy for Silent Brain Infarction | January 2018 | December 2021 |
NCT01561677 | Unknown status | N/A | Consequences of Obstructive Sleep Apnea Syndrome (OSAS) After Ischemic Subtentorial Stroke. | September 2011 | December 2020 |
- Disase is a (Disease Ontology)
- DOID:6713
- Cross Reference ID (Disease Ontology)
- MESH:D020520
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0751955
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020520